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ABSTRACT
The complex world of interstitial lung disease presents
nearly insurmountable challenges to the general surgical
pathologist faced with a lung biopsy in this setting. The
pathology is often inflammatory and always requires
clinical and radiological context for a relevant and
clinically useful histopathological diagnosis. A pattern-
based histopathological approach to interstitial lung
disease provides a ‘‘map’’ for the general pathologist to
navigate this area successfully, especially so when used
with aid of the clinical and radiological patterns of
presentation.
Few specimens cause more distress to surgical
pathologists than a biopsy sample from a patient
with diffuse lung infiltrates. The pathology
underlying this clinical and radiological presenta-
tion has been referred to as ‘‘interstitial’’ lung
disease (ILD) and is nearly always the result of
diffuse parenchymal injury, which in turn invokes
a stereotypic response of inflammation followed
inevitably by repair.
1 Unfortunately, there are
many ways to injure the lung, and it is the nature
of the injury, combined with its acuity, severity
and duration, that affects the cellular composi-
tion of the tissue response. To complicate
matters, any observed histopathology is highly
dependent on when the lung biopsy is performed
relative to the onset of a given injury. Now, add
more than one episode (or type) of injury to the
mix and little or no clinical/imaging information,
and even the most experienced histopathologist
m a yb er e a d yt os e n dt h eb i o p s ys p e c i m e no u tf o r
consultation.
How is the competent and well-trained histo-
pathologist to manage all of these variables when
the surgical lung biopsy specimen may appear at
most a few times a month in the busiest medical
centres? O n ec o u l dr e a dt h ee n t i r et e x t b o o ko n
the subject,
2 but I believe that the general
pathologist can successfully navigate this com-
plex diagnostic area, without extensive pretrain-
ing, by relying on six basic histopathological
patterns and an algorithmic approach based on
identifying the dominant pattern of disease in
the specimen.
3 These basic patterns also apply to
the much more commonly encountered trans-
bronchial biopsy specimen, but the diagnostic
patterns are more limited given the small sample
size.
4 But, before any lung biopsy is performed,
there is a patient with lung disease who is often
manageable without a biopsy if one has knowl-
edge of key clinical and radiological patterns of
disease.
5
THE THREE CLINICAL PATTERNS OF DIFFUSE
PARENCHYMAL LUNG DISEASE (ACUTE,
SUBACUTE AND CHRONIC)
All successful diagnostic strategies begin with the
patient. Before examining the lung biopsy speci-
men, it is an absolute requirement to know the
‘‘tempo’’ or pace of the patient’s respiratory
symptoms. Breathlessness is the main clinical
complaint when ILD is present, often accompanied
by cough. Knowing whether these symptoms are
acute (hours to a several days), subacute (a few
weeks to a few months) or chronic (many months
to years) allows inclusion of some diseases and
exclusion of others from the differential diagnosis.
This knowledge also helps us to determine the
nature of the critical pathology for this patient (ie,
what we should be focusing on in the specimen).
Table 1 presents my view of the diseases most
commonly associated with these three clinical
presentations.
In the patient with acute clinical manifestations,
further knowledge about immune status is very
helpful, as the index of suspicion for infection is
always higher in the immunocompromised host,
and the biopsy specimen always requires additional
studies to exclude an infectious organism (cultures
and special stains for micro-organisms).
THE FOUR RADIOLOGICAL PATTERNS OF DIFFUSE
PARENCHYMAL LUNG DISEASE (GROUND GLASS
AND CONSOLIDATION, RETICULATION WITH
PARENCHYMAL DISTORTION, NODULES AND
MOSAIC PATTERNS/CYSTS)
Chest imaging studies (today high-resolution CT
(HRCT) is used) figure prominently in the initial
clinical evaluation of the patient with ILD because
only a limited set of history and physical clues are
of independent diagnostic value. Without some
knowledge of chest imaging findings, neither
clinician nor pathologist has much hope of render-
ing an accurate and meaningful diagnosis on which
to base treatment or additional investigations.
HRCT of the chest also provides invaluable
information to the pathologist facing a surgical
lung biopsy specimen because pathologists under-
stand gross pathology better than any other
specialist in medicine, and the HRCT scan is a
reasonable approximation of gross pathology.
HRCT provides key information that is useful to
the histopathologist with a lung biopsy specimen
in hand.
5 In the setting of a patient who has
undergone a lung biopsy, four basic patterns of
radiological lung disease can be discerned: (1)
increased attenuation (referred to by our radiology
colleagues as ‘‘ground glass opacity’’ and ‘‘con-
solidation’’); (2) reticulation with parenchymal
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multiple); (4) mosaic patterns and cysts. Each of these patterns
helps me to interpret the lung biopsy findings (table 2).
THE SIX HISTOPATHOLOGICAL PATTERNS OF ILD (ACUTE
INJURY, FIBROSIS, CELLULAR INFILTRATES, AIRSPACE
FILLING, NODULES, MINIMAL CHANGES)
In the setting of ILD, it is the rare lung biopsy specimen that has
sufficiently unambiguous findings to allow a disease diagnosis
(eg, Wegener granulomatosis). In our lung consultation practice,
the majority of non-neoplastic lung cases receive descriptive
diagnoses, followed by a narrow differential diagnosis and a
comment on any additional information that may help to
resolve a ‘‘clinical–radiological–histopathological’’ diagnosis.
This can be an uncomfortable position for pathologists trained
to provide a terse ‘‘black or white’’ diagnosis lest they be
accused of ‘‘hedging’’ their risk against error. The reason that
naming a specific disease in this setting does not work is that
inflammatory processes tend to overlap one another with regard
to clinical, radiological, physiological and histopathological
features. Despite these stated limitations, the histopathological
findings in the lung biopsy do provide critical information about
the aetiology, activity, age, reversibility and prognosis of a given
case of ILD.
With the microscope, experienced pathologists generally rely
on the low magnification pattern of disease, rapidly gaining an
overall sense of a histopathological diagnosis using patterns that
may not be well articulated by the observer. Unfortunately,
ILDs are not biopsied often enough for pathologists to gain first
hand experience in view of the exceptionally broad spectrum of
this pathology. To circumvent this problem, I teach pathologists
to use six basic histopathological patterns in the evaluation of
the ILD biopsy specimen. Once the dominant pattern is
identified, the differential diagnosis becomes more manageable.
Additional findings help to resolve the diagnosis even further.
Table 3 presents the six patterns of diffuse lung disease with
their respective differential diagnoses.
An algorithmic approach using additional findings can be
found online in supplemental table 1. Because of space
constraints, I will limit discussion and illustration to the more
commonly encountered diseases outlined in these tables.
Further exposition of the entities listed in table 3 can be found
in a number of excellent textbooks on pulmonary pathology.
We begin with pattern 1 (acute lung injury) because acute
clinical symptoms dominate all other concerns regarding the
biopsy. Fortunately, these are the easiest cases for pathologists
to resolve as long as a few simple rules and a consistent
approach is used.
PATTERN 1: ACUTE LUNG INJURY
Basic elements of the pattern: interstitial oedema, intra-
alveolar fibrin and reactive type 2 cells (fig 1).
Table 1 The three clinical patterns of diffuse lung disease and their
differential diagnosis
Acute (hours to several
days)
Subacute (weeks to
several months)
Chronic (many months to
years)
c Infection c Hypersensitivity
pneumonitis
c Related to rheumatic
disease
c Diffuse alveolar
damage
c Smoking-related disease c Related to drugs
c Acute eosinophilic
pneumonia
c Sarcoidosis/berylliosis c Pneumoconioses
c Acute injury related
to drugs
c Related to rheumatic
disease
c Smoking-related disease
c Acute injury related
to fumes and toxins
c Related to drugs c Sarcoidosis/berylliosis
c Acute injury related
to rheumatic
disease
c Certain infections c Alveolar proteinosis
c Vasculitis c Alveolar proteinosis c Small-airways disease
c Diffuse alveolar
haemorrhage
c Chronic eosinophilic
pneumonia
c Amyloidosis
c Acute exacerbation
of chronic disease
c Cryptogenic organising
pneumonia
c Usual interstitial
pneumonia
c Acute interstitial
pneumonia
(idiopathic)
c Non-specific interstitial
pneumonia
c Non-specific interstitial
pneumonia
c Lymphoid interstitial
pneumonia
Table 2 The four radiological patterns of diffuse lung disease
Pattern 1
Ground glass and consolidation
Pattern 2
Fibrosis
Pattern 3
Nodules
Pattern 4
Mosaic patterns/cysts
c Oedema c Pneumoconioses c Carcinomas and sarcomas c Small-airways disease
with constrictive bronchiolitis
c Infection c Chronic granulomatous infection c Lymphoproliferative diseases c Vasculopathic diseases
c Aspiration c Usual interstitial pneumonia c Miliary granulomatous infections c Lymphangioleiomyomatosis
c Hypersensitivity pneumonitis (extrinsic
allergic alveolitis)
c Chronic hypersensitivity pneumonitis c Aspiration bronchiolitis c Langerhans cell histiocytosis
c Drug reactions (toxic and
hypersensitivity)
c Related to rheumatic disease c Hypersensitivity pneumonitis
c Fumes and toxin injury c Chronic drug reactions c Pulmonary Langerhans cell histiocytosis
c Related to rheumatic disease c Sarcoidosis c Sarcoidosis
c Idiopathic interstitial pneumonias c Lymphoid interstitial pneumonia c Wegener granulomatosis
– Non-specific interstitial
pneumonia
c Fibrotic non-specific interstitial
pneumonia
c Necrotising sarcoidosis
– Lymphoid interstitial pneumonia c Chronic aspiration c Silicosis and silicate disease
– Desquamative interstitial
pneumonia
c Chronic radiation injury
c Respiratory bronchiolitis-associated
interstitial lung disease
c Advanced Langerhans cell histiocytosis
c Lymphangitic tumours c Hermansky–Pudlak syndrome
c Wegener granulomatosis
(haemorrhage variant)
c Erdheim–Chester disease (non-
Langerhans cell histiocytosis)
c Alveolar proteinosis
c Amyloidosis
My approach
388 J Clin Pathol 2009;62:387–401. doi:10.1136/jcp.2008.059782T
a
b
l
e
3
T
h
e
s
i
x
h
i
s
t
o
p
a
t
h
o
l
o
g
i
c
a
l
p
a
t
t
e
r
n
s
o
f
d
i
f
f
u
s
e
l
u
n
g
d
i
s
e
a
s
e
s
P
a
t
t
e
r
n
1
(
a
c
u
t
e
l
u
n
g
i
n
j
u
r
y
)
P
a
t
t
e
r
n
2
(
f
i
b
r
o
s
i
s
)
P
a
t
t
e
r
n
3
(
c
e
l
l
u
l
a
r
i
n
f
i
l
t
r
a
t
e
s
)
P
a
t
t
e
r
n
4
(
a
l
v
e
o
l
a
r
f
i
l
l
i
n
g
)
P
a
t
t
e
r
n
5
(
n
o
d
u
l
e
s
;
s
m
a
l
l
o
r
l
a
r
g
e
,
s
i
n
g
l
e
o
r
m
u
l
t
i
p
l
e
)
P
a
t
t
e
r
n
6
(
m
i
n
i
m
a
l
c
h
a
n
g
e
s
)
c
D
i
f
f
u
s
e
a
l
v
e
o
l
a
r
d
a
m
a
g
e
(
a
n
y
c
a
u
s
e
;
s
e
e
b
o
x
1
)
c
P
n
e
u
m
o
c
o
n
i
o
s
e
s
c
H
y
p
e
r
s
e
n
s
i
t
i
v
i
t
y
p
n
e
u
m
o
n
i
t
i
s
(
s
u
b
a
c
u
t
e
d
i
s
e
a
s
e
)
c
P
u
l
m
o
n
a
r
y
o
e
d
e
m
a
c
N
e
o
p
l
a
s
m
s
(
p
r
i
m
a
r
y
o
r
m
e
t
a
s
t
a
t
i
c
)
c
P
u
l
m
o
n
a
r
y
o
e
d
e
m
a
c
I
n
f
e
c
t
i
o
n
s
c
U
s
u
a
l
i
n
t
e
r
s
t
i
t
i
a
l
p
n
e
u
m
o
n
i
a
c
D
r
u
g
r
e
a
c
t
i
o
n
s
c
A
c
u
t
e
b
r
o
n
c
h
o
p
n
e
u
m
o
n
i
a
c
G
r
a
n
u
l
o
m
a
t
o
u
s
i
n
f
e
c
t
i
o
n
s
(
s
e
e
b
o
x
7
f
o
r
c
a
u
s
e
s
o
f
g
r
a
n
u
l
o
m
a
s
i
n
b
i
o
p
s
y
s
p
e
c
i
m
e
n
s
)
c
A
v
e
r
y
s
u
b
t
l
e
i
n
t
e
r
s
t
i
t
i
a
l
i
n
f
i
l
t
r
a
t
e
c
D
r
u
g
r
e
a
c
t
i
o
n
s
c
C
h
r
o
n
i
c
h
y
p
e
r
s
e
n
s
i
t
i
v
i
t
y
p
n
e
u
m
o
n
i
t
i
s
c
R
e
l
a
t
e
d
t
o
r
h
e
u
m
a
t
i
c
d
i
s
e
a
s
e
s
c
A
c
u
t
e
e
o
s
i
n
o
p
h
i
l
i
c
p
n
e
u
m
o
n
i
a
c
P
n
e
u
m
o
c
o
n
i
o
s
e
s
(
e
s
p
e
c
i
a
l
l
y
s
i
l
i
c
a
-
r
e
l
a
t
e
d
)
c
P
u
l
m
o
n
a
r
y
e
m
b
o
l
i
(
i
n
c
l
u
d
i
n
g
f
a
t
e
m
b
o
l
i
)
c
R
e
l
a
t
e
d
t
o
r
h
e
u
m
a
t
i
c
d
i
s
e
a
s
e
c
R
e
l
a
t
e
d
t
o
r
h
e
u
m
a
t
i
c
d
i
s
e
a
s
e
c
L
y
m
p
h
o
p
r
o
l
i
f
e
r
a
t
i
v
e
d
i
s
e
a
s
e
s
c
U
n
u
s
u
a
l
i
n
f
e
c
t
i
o
n
s
w
i
t
h
p
r
o
m
i
n
e
n
t
h
i
s
t
i
o
c
y
t
e
s
(
e
g
,
R
h
o
d
o
c
o
c
c
u
s
e
q
u
i
)
c
A
s
p
i
r
a
t
i
o
n
c
C
o
n
s
t
r
i
c
t
i
v
e
b
r
o
n
c
h
i
o
l
i
t
i
s
c
R
e
l
a
t
e
d
t
o
t
o
x
i
n
s
,
f
u
m
e
s
a
n
d
g
a
s
e
s
c
C
h
r
o
n
i
c
d
r
u
g
r
e
a
c
t
i
o
n
s
c
N
o
n
-
s
p
e
c
i
f
i
c
i
n
t
e
r
s
t
i
t
i
a
l
p
n
e
u
m
o
n
i
a
c
A
l
v
e
o
l
a
r
h
a
e
m
o
r
r
h
a
g
e
c
N
o
d
u
l
a
r
d
r
u
g
r
e
a
c
t
i
o
n
(
e
g
,
a
m
i
o
d
a
r
o
n
e
)
c
V
a
s
c
u
l
o
p
a
t
h
i
c
d
i
s
e
a
s
e
s
c
A
c
u
t
e
e
o
s
i
n
o
p
h
i
l
i
c
p
n
e
u
m
o
n
i
a
(
s
e
e
b
o
x
2
)
c
A
d
v
a
n
c
e
d
s
a
r
c
o
i
d
o
s
i
s
c
C
e
r
t
a
i
n
i
n
f
e
c
t
i
o
n
s
(
e
g
,
r
i
c
k
e
t
t
s
i
a
,
m
y
c
o
p
l
a
s
m
a
,
H
I
V
)
c
D
e
s
q
u
a
m
a
t
i
v
e
i
n
t
e
r
s
t
i
t
i
a
l
p
n
e
u
m
o
n
i
a
(
D
I
P
;
s
e
e
b
o
x
6
f
o
r
c
a
u
s
e
s
o
f
D
I
P
-
l
i
k
e
r
e
a
c
t
i
o
n
s
)
c
S
a
r
c
o
i
d
o
s
i
s
/
b
e
r
y
l
l
i
o
s
i
s
c
C
y
s
t
i
c
d
i
s
e
a
s
e
s
c
A
l
v
e
o
l
a
r
h
a
e
m
o
r
r
h
a
g
e
s
y
n
d
r
o
m
e
s
(
s
e
e
b
o
x
3
)
c
F
i
b
r
o
t
i
c
n
o
n
-
s
p
e
c
i
f
i
c
i
n
t
e
r
s
t
i
t
i
a
l
p
n
e
u
m
o
n
i
a
c
L
y
m
p
h
o
i
d
i
n
t
e
r
s
t
i
t
i
a
l
p
n
e
u
m
o
n
i
a
c
R
e
s
p
i
r
a
t
o
r
y
b
r
o
n
c
h
i
o
l
i
t
i
s
-
a
s
s
o
c
i
a
t
e
d
i
n
t
e
r
s
t
i
t
i
a
l
l
u
n
g
d
i
s
e
a
s
e
c
L
a
n
g
e
r
h
a
n
s
c
e
l
l
h
i
s
t
i
o
c
y
t
o
s
i
s
c
L
y
m
p
h
a
n
g
i
o
l
e
i
o
m
y
o
m
a
t
o
s
i
s
c
T
r
a
n
s
p
l
a
n
t
r
e
j
e
c
t
i
o
n
c
C
h
r
o
n
i
c
a
s
p
i
r
a
t
i
o
n
c
O
r
g
a
n
i
s
i
n
g
p
n
e
u
m
o
n
i
a
(
a
n
y
c
a
u
s
e
;
s
e
e
b
o
x
5
)
c
W
e
g
e
n
e
r
g
r
a
n
u
l
o
m
a
t
o
s
i
s
c
L
a
n
g
e
r
h
a
n
s
c
e
l
l
h
i
s
t
i
o
c
y
t
o
s
i
s
c
I
d
i
o
p
a
t
h
i
c
f
o
r
m
s
(
a
c
u
t
e
i
n
t
e
r
s
t
i
t
i
a
l
p
n
e
u
m
o
n
i
a
a
n
d
‘
‘
a
c
u
t
e
f
i
b
r
i
n
o
u
s
a
n
d
o
r
g
a
n
i
s
i
n
g
p
n
e
u
m
o
n
i
a
’
’
)
6
c
C
h
r
o
n
i
c
r
a
d
i
a
t
i
o
n
i
n
j
u
r
y
c
O
r
g
a
n
i
s
i
n
g
p
n
e
u
m
o
n
i
a
(
c
r
y
p
t
o
g
e
n
i
c
)
c
P
e
r
s
i
s
t
e
n
t
o
r
g
a
n
i
s
i
n
g
p
n
e
u
m
o
n
i
a
c
S
a
m
p
l
i
n
g
e
r
r
o
r
c
A
d
v
a
n
c
e
d
L
a
n
g
e
r
h
a
n
s
c
e
l
l
h
i
s
t
i
o
c
y
t
o
s
i
s
c
A
l
v
e
o
l
a
r
p
r
o
t
e
i
n
o
s
i
s
c
P
u
l
m
o
n
a
r
y
h
y
a
l
i
n
i
s
i
n
g
g
r
a
n
u
l
o
m
a
c
H
e
r
m
a
n
s
k
y
–
P
u
d
l
a
k
s
y
n
d
r
o
m
e
c
A
c
u
t
e
f
i
b
r
i
n
o
u
s
a
n
d
o
r
g
a
n
i
s
i
n
g
p
n
e
u
m
o
n
i
a
(
c
r
y
p
t
o
g
e
n
i
c
)
c
P
l
a
s
m
a
c
e
l
l
g
r
a
n
u
l
o
m
a
c
E
r
d
h
e
i
m
–
C
h
e
s
t
e
r
d
i
s
e
a
s
e
(
n
o
n
-
L
a
n
g
e
r
h
a
n
s
c
e
l
l
h
i
s
t
i
o
c
y
t
o
s
i
s
)
c
D
e
n
d
r
i
f
o
m
c
a
l
c
i
f
i
c
a
t
i
o
n
c
L
u
n
g
i
n
f
a
r
c
t
c
I
d
i
o
p
a
t
h
i
c
a
i
r
w
a
y
-
c
e
n
t
r
e
d
f
i
b
r
o
s
i
s
c
A
l
v
e
o
l
a
r
m
i
c
r
o
l
i
t
h
i
a
s
i
s
c
R
o
s
a
i
–
D
o
r
f
m
a
n
d
i
s
e
a
s
e
My approach
J Clin Pathol 2009;62:387–401. doi:10.1136/jcp.2008.059782 389Key modifiers: hyaline membranes, tissue necrosis, eosinophils
and fibrin in alveoli, haemosiderin-laden macrophages, back-
ground fibrosis (acute on chronic disease).
Acutelunginjuryisthehistopathologicalpatternassociatedwith
acute clinical lung disease. Onset of symptoms typically occurs
hours, days or a week or two before biopsy. Several subtypes of
acute lung injury are recognised histopathologically (diffuse
alveolar damage (DAD), acute eosinophilic pneumonia, acute
fibrinousandorganisingpneumonia(OP),diffusealveolarhaemor-
rhage). When specific findings are incomplete (ie, no hyaline
membranes), the generic term ‘‘acute lung injury’’ is appropriate.
1a: acute lung injury with hyaline membranes (DAD)
When intra-alveolar hyaline membranes are present, the term
‘‘diffuse alveolar damage (DAD)’’ is appropriate. DAD is a
common histopathological pattern of injury in acute diffuse
lung disease (fig 2), particularly in patients with clinical adult
respiratory distress syndrome and those who are immunosup-
pressed.
78DAD is a diffuse process as the name implies, but it is
not always uniform in severity or appearance from one
microscopic field to another. DAD is associated with the
conditions presented in box 1.
In the immunocompromised patient, infection leads the
differential diagnosis. DAD can also occur in patients with
idiopathic pulmonary fibrosis and other chronic ILDs, possibly
as a natural component of the disease evolution.
91 0
1b: acute lung injury with necrosis
Tissue necrosis raises a differential diagnosis of infection,
infarction, neoplasm and Wegener granulomatosis (and similar
conditions such as so-called necrotising sarcoidosis and some-
times Churg–Strauss syndrome). When necrosis is present (fig 3)
in the acutely ill patient, infection leads the differential
diagnosis, even if special stains are negative. Conversely the
lack of necrosis in a biopsy specimen from an acutely ill patient
with normal immunity virtually eliminates clinically significant
infection as the primary aetiology in my experience.
1c: acute lung injury with alveolar eosinophils
Tissue eosinophils play important roles in a number of toxic,
infectious and immunological lung reactions.
11 When many
eosinophils are visible in the airspaces (fig 4) in a patient with
acute lung disease, a diagnosis of acute eosinophilic pneumonia
is appropriate.
12 This finding is a vital key to potentially reversible
disease and should never be discounted or overlooked. Potential
causes of eosinophilic pneumonia are presented in box 2.
1d: acute lung injury with diffuse alveolar haemorrhage
Evidence of recent and remote haemorrhage in the lung is the
most important histopathological feature for distinguishing
immunologically mediated haemorrhage syndromes from other
forms of acute lung injury.
14 Diseases such as Wegener
granulomatosis and Goodpasture syndrome may show con-
siderable histopathological overlap with those producing DAD.
15
In most instances, pulmonary haemorrhage is recognised as the
clinical problem because the patient has experienced one or
more episodes of haemoptysis, but this can be an inconsistent
finding.
At scanning magnification, the biopsy specimen of the diffuse
alveolar haemorrhage lung has variable fresh blood in the
parenchyma, typically associated with fibrin and haemosiderin-
filled alveolar macrophages (fig 5). In more chronic examples,
this dense macrophage reaction may even mimic the idiopathic
interstitial pneumonia referred to as ‘‘desquamative interstitial
pneumonia’’ (DIP) (see below). OP is common in this setting
and is often associated with fibrin in the alveoli, the latter being
vital for the correct assessment that one is dealing with an acute
process (alveolar fibrin is not an expected finding in idiopathic
DIP). The most common pulmonary haemorrhage syndromes
and other disease processes associated with diffuse pulmonary
haemorrhage are presented in box 3.
Capillaritis is a distinctive histopathological feature seen in
some alveolar haemorrhage syndromes (fig 6). Capillaritis can be
Figure 1 Pattern 1: acute lung injury. At scanning magnification (26
objective), the biopsy sections have an eosinophilic appearance. H&E
stain, 156original magnification.
Special stains for organisms are required for all lung specimens
that show acute injury
Figure 2 Diffuse alveolar damage. (A)
Alveoli are empty and lined by hyaline
membranes or (B) variably filled by
oedema, macrophages and immature
fibroblasts (organisation; OP). Residual
hyaline membranes are often present
(arrow). H&E stain, 1006original
magnification.
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identify once the other features of alveolar haemorrhage are
encountered because the presence of capillaritis is considered a
medical emergency and requires an immediate call to the
clinician (patients are at risk of fatal haemoptysis).
Serological studies are essential in documenting an immuno-
logical mechanism and providing information on the presence of
a specific haemorrhage syndrome (eg, anti-nuclear antibodies,
anti-neutrophil cytoplasmic antibodies, anti-glomerular base-
ment membrane antibodies). We do not perform tissue
immunofluorescence studies routinely in biopsy material,
mainly because the serological data are more consistent, quite
reliable, and preferred for treatment selection by many clinical
experts today. Sometimes the pigmented alveolar macrophages
of smokers can simulate the siderophages of pulmonary
haemorrhage. The fine granularity of the brown pigment in
these cells and the consistent presence of dot-like black pigment
particles in the cytoplasm helps in their proper identification.
1e: acute lung injury with background fibrosis (acute on chronic
disease)
Acute lung injury can occur as a natural escalation of an
underlying chronic lung disease, such as acute exacerbation of
idiopathic pulmonary fibrosis.
91 0Alternatively, a patient may
have a stable chronic lung disease on which community-
acquired pneumonia or drug toxicity is now superimposed. I
refer to this combination of histopathology as ‘‘acute on chronic
lung disease’’ and always append a comment regarding the
diagnostic possibilities in this scenario (one disease versus two
or more).
PATTERN 2: FIBROSIS
Basic elements of the pattern: dense collagen deposition in
the lung parenchyma, often accompanied by some degree of
structural remodelling with alveolar loss (fig 7).
Key modifiers: with temporal heterogeneity, with uniform
alveolar wall fibrosis, with airway-centred scarring, with
isolated stellate scars, with microscopic honeycombing only,
with pleuritis.
Interstitial lung fibrosis is often accompanied by permanent
and irreversible alteration of lung architecture. Pattern 2
(fibrosis) tends to carry great prognostic significance for the
patient and is only superseded in importance by pattern 1 (acute
lung injury). Different patterns of fibrosis probably derive from
different injury mechanisms, carry different prognostic implica-
tions, and one day may influence targeted treatments. Large,
often stacked, cystic spaces that can be seen on CT scans of the
chest and in whole-lung sections and referred to as ‘‘honeycomb
cysts’’ are often recapitulated (or preceded) at the microscopic
level, where the process is referred to as ‘‘microscopic
honeycombing’’ (fig 8). A general morphological approach to
Box 1: conditions associated with diffuse alveolar
damage
78
c Infections (viral, fungal, bacterial, parasitic)
c Toxic inhalants
c Drug reactions
c Shock
c Systemic collagen vascular diseases
c Radiation reactions (acute)
c Acute allergic reactions (eg, hypersensitivity pneumonitis)
c Alveolar haemorrhage syndromes
c Miscellaneous conditions
c Idiopathic disease (acute interstitial pneumonia)
Figure 3 Acute injury with necrosis. Necrosis (N) is a harbinger of
infection in the context of pattern 1 and an acutely ill patient. Infection
always leads the differential diagnosis in this situation, even if special
stains are negative. H&E stain, 1006original magnification.
Figure 4 Acute eosinophilic pneumonia.
(A) When many eosinophils are visible in
the airspaces in a patient with acute lung
disease, a diagnosis of acute eosinophilic
pneumonia is appropriate.
(B) Organisation in alveolar spaces, and
rarely hyaline membranes, may be
present. (A,B) H&E stain, 1006original
magnification.
Box 2: causes of eosinophilic lung disease
13
c Certain infections and parasitic diseases
c Asthma and asthma-related lung diseases
c Churg–Strauss syndrome
c Drug reaction
c Acute eosinophilic pneumonia (idiopathic)
c Acute smoking-related disease (rare)
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distribution and character of the fibrotic or fibroblastic reaction,
the degree and extent of mature interstitial scarring, and the
presence or absence of microscopic honeycomb remodelling.
2a: fibrosis with temporal heterogeneity
Usual interstitial pneumonia (UIP) is the prototypic chronic
interstitial pneumonia with ‘‘temporally heterogeneous’’ inter-
stitial fibrosis and honeycombing (both microscopic and
macroscopic), originally described by Liebow and Carrington.
16
Patients with cryptogenic fibrosing alveolitis have UIP on
surgical lung biopsy.
17 UIP is characterised by zones of normal
lung tissue adjacent to zones of advanced architectural
remodelling (fig 9).
18 The latter is recognised by confluent and
dense scarring of the alveolar parenchyma. Microscopic honey-
combing occurs early in the process and consists of irregular
cysts containing mucus, aggregated in dense fibrosis (fig 10). For
me, microscopic honeycombing requires fibrosis on at least
three sides of the aggregated cysts, a criterion that helps to avoid
including foci of peribronchiolar metaplasia under this designa-
tion. Small discrete foci of active fibroplasia are always present
in UIP, but they are not specific for UIP. These ‘‘fibroblastic
foci’’ occur at the interface between dense scar and adjacent
normal lung (fig 11). These three key elements of UIP are
often related to one another in the biopsy specimen, as a
transition from old disease (fibrosis) to normal lung occurs,
with active ‘‘fibroblast foci’’ forming a leading edge between
them (this is the concept underlying the term ‘‘temporal
Figure 5 Diffuse alveolar haemorrhage.
(A) The lung biopsy specimen has
variable fresh blood in the parenchyma,
typically associated with fibrin, reactive
type 2 cells and haemosiderin-filled
alveolar macrophages (B). This reaction
pattern may be associated with
immunologically mediated injury. (A,B)
H&E stain; (A) 406original magnification;
(B) 4006original magnification.
Box 3: causes of diffuse alveolar haemorrhage
14
c Goodpasture syndrome (anti-glomerular basement membrane
antibody disease)
c Vasculitides (especially Wegener granulomatosis)
c Mitral stenosis
c IgA nephropathy
c Behcet syndrome
c Certain systemic collagen vascular diseases (especially
systemic lupus erythematosus)
c HIV infection
c Anti-phospholipid syndrome
c Pulmonary veno-occlusive disease
c Idiopathic pulmonary haemosiderosis
c Drug reactions, including toxic reactions and anticoagulants
c Acute lung allograft rejection
c Unclassified forms
Figure 6 Capillaritis in diffuse alveolar
haemorrhage. (A) The presence of
capillaritis is one of the few medical
emergencies in pulmonary pathology.
Capillaritis is distinctive but can be quite
focal in the biopsy specimen. Here a
‘‘pseudo-bronchopneumonia’’ pattern is
present, with shed neutrophils filling
alveolar spaces. (B) Here the neutrophils
are still within the alveolar walls. (A,B)
H&E stain; (A) 406original magnification;
(B) 4006original magnification.
Figure 7 Pattern 2 fibrosis. Fibrosis in the lung parenchyma should be
diagnosed only when it is dense, and never in the transbronchial biopsy
specimen. Note the distortion of the alveolar parenchyma and fusion of
alveolar walls.
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destroyed by fibrosis, tomorrow’s lung waiting to be consumed,
and fibroblast foci sitting at the interface (today)). A peripheral
acinar pattern can often be recognised in UIP, accompanied by
relative centriacinar sparing. These findings help to distinguish
UIP from other lesions (see below) with interstitial fibrosis and
honeycombing (box 4). Rarely, other diseases can simulate the
‘‘UIP pattern’’, such as chronic hypersensitivity pneumonitis, the
rheumatic diseases and asbestosis.
2b: fibrosis with uniform alveolar wall involvement
The occurrence of ‘‘interstitial’’ fibrosis that tends to preserve
alveolar structure (ie, little confluence of scar) characterises a
fairly limited group of ILDs, dominated by rheumatic diseases,
chronic drug reactions and some examples of chronic hypersen-
sitivity (fig 12). An idiopathic form (referred to as ‘‘fibrotic non-
specific pneumonia’’ or simply ‘‘NSIP’’) was formally described
by Katzenstein and Fiorelli
19 in 1994, who reported on 64
patients whose lung biopsy specimens showed cellular inter-
stitial inflammatory changes that did not fit within the
spectrum of diseases originally described in the Liebow historical
classification of the idiopathic interstitial pneumonias. In their
report, they coined the term ‘‘non-specific interstitial/fibrosis
(NSIP/F)’’ for the patterns identified, and openly recognised
that these patterns probably represented a wide variety of
inflammatory processes affecting the lung. These authors
Figure 8 Honeycomb remodelling. (A)
Large, often stacked, cystic spaces seen
in whole-lung sections are referred to as
‘‘honeycomb cysts’’. (B) These are often
recapitulated (or preceded) at the
microscopic level, where the process is
referred to as ‘‘microscopic
honeycombing’’. (A) Gross image; (B)
H&E stain, 16original magnification.
Figure 9 Usual interstitial pneumonia
(UIP). UIP is characterised by zones of
normal lung tissue adjacent to zones of
advanced architectural remodelling
(temporal heterogeneity). (A) Early in the
disease process, an interrupted ‘‘rind’’ of
subpleural fibrosis is visible. (B) A more
advanced stage shows more extensive
perilobular fibrosis with relative
centrilobular sparing, producing ring-like
scarring at scanning magnification. (A,B)
H&E stain, 16original magnification.
Figure 10 Microscopic honeycombing. This finding occurs early in
usual interstitial pneumonia and consists of irregular microscopic cysts
containing mucus (with neutrophils) and lined by ciliated columnar
epithelium. H&E stain, 406original magnification.
Figure 11 Fibroblast foci. Discrete ‘‘bulges’’ of immature fibroblasts in
amphophilic matrix are referred to as ‘‘fibroblast’’ or ‘‘fibroblastic’’ foci.
They occur at the interface between dense scar and adjacent normal
lung. In a three-dimensional reconstruction study, the foci appear to be
interconnected into a lattice. These lesions are thought to be the focus of
ongoing injury and repair in usual interstitial pneumonia (UIP), but are not
unique to UIP. H&E stain, 2006original magnification.
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process—that is, the pathology seemed to reflect a single injury
in time (ie, lacking a spectrum ranging from new disease to old).
Perhaps the most important aspect of the Katzenstein and
Fiorelli study was the discovery that, in patients with NSIP,
morbidity and mortality were significantly different from that
expected for UIP.
20
2c: fibrosis with an airway-centred distribution
When scarring occurs diffusely around bronchioles (fig 13), the
differential diagnosis generally is limited to inhalation (eg,
hypersensitivity pneumonitis)
21 and aspiration-associated injury
and certain rheumatic or immune-mediated systemic conditions
(eg, rheumatoid arthritis, Sjogren syndrome). An idiopathic
form has been described.
22 23 In some biopsy samples, the
airway-centred nature of the process may be difficult to discern,
especially when fibrosis is advanced and/or the sample is small.
The HRCT distribution may be helpful, as UIP and the
autoimmune diseases tend to involve the periphery and lower
lung zones, whereas diffuse inhalational injuries tend to have a
more mid-zone and upper lung zone distribution (at least
relatively early in the process).
2d: fibrosis with isolated stellate scars
The late stages of the smoking-related lung disease known as
Langerhans cell histiocytosis (LCH) are characterised by the
presence of stellate parenchymal scars (fig 14).
24 These scars are
distinctive and typically have few or no residual Langerhans
cells. We refer to these as ‘‘healed’’ lesions of LCH. They may be
incidental when the biopsy is performed for localised disease
(such as carcinoma). In the setting of ILD, a form of ‘‘smoking-
related interstitial lung disease’’ should be considered as the
correct diagnosis.
2e: fibrosis with microscopic honeycombing only
Many unrelated lung diseases can result in localised areas of
complete structural remodelling (end-stage lung) with the
formation of microscopic honeycomb cysts in fibrosis.
Context is essential. If microscopic honeycombing dominates
the entire biopsy sample, the patient is over 60 years of age, and
Box 4: diseases with fibrosis/honeycombing (modified
from Leslie et al
1)
c Idiopathic pulmonary fibrosis (idiopathic usual interstitial
pneumonia)
c Desquamative interstitial pneumonia
c Lymphoid interstitial pneumonia
c Systemic collagen vascular disease
c Chronic drug reactions
c Pneumoconioses (asbestosis, berylliosis, silicosis, hard metal
pneumoconiosis, others)
c Sarcoidosis
c Pulmonary Langerhans cell histiocytosis (histiocytosis X)
c Chronic granulomatous infections
c Chronic aspiration
c Chronic hypersensitivity pneumonitis
c Organised, and organising, diffuse alveolar damage
c Chronic interstitial pulmonary oedema/passive congestion
c Radiation injury (chronic)
c Healed infectious pneumonias and other inflammatory
processes
c Non-specific interstitial pneumonia/fibrosis
c Erdheim–Chester disease
c Hermansky–Pudlak syndromes
Figure 12 Diffuse alveolar wall fibrosis. Sometimes ‘‘interstitial’’
fibrosis preserves alveolar structure (ie, little confluence of scar) invoking
a fairly limited differential diagnosis, dominated by rheumatic diseases,
chronic drug reactions and some examples of chronic hypersensitivity.
When no underlying aetiology is present, the term ‘‘idiopathic NSIP’’ is
appropriate. H&E stain, 406original magnification.
Figure 13 Airway-centred fibrosis. Fibrosis around bronchioles is
typically a manifestation of inhalational or aspiration injury to the lungs.
H&E stain, 156original magnification.
Figure 14 Langerhans cell histiocytosis (LCH). The star-shaped,
airway-centred scars of LCH are distinctive and may be a sign of
resolved disease. H&E stain, 156original magnification.
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diagnosis is nearly always cryptogenic fibrosing alveolitis.
Nevertheless, in this setting, pathologists should use the
descriptive term ‘‘advanced microscopic honeycomb remodel-
ling only’’, because the UIP diagnosis today requires some
normal preserved lung in the biopsy specimen to establish
‘‘temporal heterogeneity’’.
2f: fibrosis with pleuritis
The pleura is an organ separate from the lung. When the lung
biopsy sample shows fibrosis, and the pleura is actively inflamed
(acute or chronic), always consider one of the rheumatic
diseases as a potential aetiology.
PATTERN 3: CHRONIC INFLAMMATORY (CELLULAR)
INFILTRATES
Basic elements of the pattern: chronic inflammatory cells
present diffusely within alveolar walls, often with variable
intensity (fig 15).
Key modifiers: with pure cellular interstitial pneumonia, with
poorly formed granulomas, with well-formed granulomas, with
diffuse alveolar wall fibrosis (see pattern 2b), with confluent
dense fibrosis (see pattern 2a; simulators of the UIP pattern)
Diffuse infiltration of the lung parenchyma by inflammatory
cells (typically including lymphocytes and plasma cells) is a very
common pattern among ILDs, and often not particularly helpful
in arriving at a specific diagnosis. The diseases that produce
mononuclear interstitial infiltrates tend to overlap in their
response to treatment and patient prognosis. The more
common diseases in this pattern are presented here.
3a: cellular infiltrates with pure cellular interstitial pneumonia
(lymphocytes and plasma cells)
Cellular interstitial pneumonia patterns of ILD had been
recognised by pulmonary pathologists for many years, but they
lacked a champion until 1994, when Katzenstein and Fiorelli
described their 64 patients with NSIP.
19 Three histopathological
patterns were evident in their series. One was a pure cellular
form (group 1; fig 16), whereas two others had variable
interstitial fibrosis (discussed under pattern 2b). In practice,
this ‘‘group 1’’ of NSIP is rare.
3b: cellular interstitial pneumonia with poorly formed
granulomas
The prototype of this pattern of ILD is hypersensitivity
pneumonitis (HP) to inhaled organic antigen, also known as
extrinsic allergic alveolitis (fig 17).
25–28 Other inflammatory lung
diseases can mimic HP in both the subacute and chronic forms
of the disease. I always include drug reaction, systemic
autoimmune disease and even evolving low-grade lymphopro-
liferative disease in the differential when this pattern is
encountered. Helpful HRCT findings favouring subacute HP
(the form most consistently cellular in lung biopsy specimens)
include the presence of ill-defined centrilobular nodules in the
mid and upper lung zones.
29 The idiopathic interstitial
Figure 15 Pattern 3: chronic inflammatory (cellular) infiltrates. The
biopsy specimen in pattern 3 tends to have a blue appearance because
of the interstitial infiltrates of mononuclear cells (mainly lymphocytes and
plasma cells) with their haematoxylin-stained nuclei and scant
cytoplasm. H&E stain, 156original magnification.
Figure 16 Non-specific interstitial pneumonia (NSIP), cellular. The pure
cellular form of NSIP is rare. If small poorly formed granulomas are
present, hypersensitivity pneumonitis should be considered. If foci of
organising pneumonia are present, without granulomas, cryptogenic
organising pneumonia should be considered. H&E stain, 406original
magnification.
Figure 17 Hypersensitivity pneumonitis
(HP). The cellular interstitium of subacute
HP (A) is dominated by plasma cells
(magnification in B). A typical poorly
formed granuloma of HP is present in (B).
(A,B) H&E stain; (A) 406original
magnification; (B) 4006original
magnification.
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‘‘lymphoid interstitial pneumonia (LIP)’’. Lymphoma must be
excluded before a diagnosis of LIP can be rendered.
3c: cellular interstitial pneumonia with well-formed granulomas
Infection dominates this pattern of cellular interstitial pneu-
monia, followed by subacute/chronic aspiration pneumonia,
especially if the granulomas are present in alveoli or alveolar
ducts (fig 18). Atypical mycobacteria dominate this diffuse lung
disease presentation, including a form of bioaerosol exposure to
atypical mycobacteria (so-called ‘‘hot tub lung’’).
30 When
granulomas are interstitial and resemble those of sarcoidosis
(see below), the presence of cellular infiltrates is best reconciled
as a different disease process (eg, drug reaction and sarcoidosis).
PATTERN 4: ALVEOLAR FILLING
Basic elements of the pattern: alveoli in the biopsy specimen
filled with cells or non-cellular material (fig 19).
Key modifiers: with immature fibroblasts, with macrophages,
with proteinaceous material, with blood and siderophages, with
neutrophils.
This pattern of lung disease occurs as a component of a
number of different pathological processes such as acute and
organising infections, pulmonary haemorrhage, pulmonary
alveolar proteinosis (PAP), chronic eosinophilic pneumonia,
DIP, respiratory bronchiolitis-associated interstitial lung disease
(RB-ILD) and many others. Parenchymal consolidation alone is
not helpful in the differential diagnosis except when the filling
process is distinctive or nearly diagnostic, such as PAP (granular
proteinaceous material) or chronic eosinophilic pneumonia
(pink macrophages, fibrin and eosinophils).
4a: alveolar filling with immature fibroblasts (OP pattern)
The OP pattern is a very common reaction pattern in the lung.
The presence of intraluminal tufts of plump fibroblasts and
immature connective tissue within alveolar ducts and more
distal airspaces has been traditionally referred to as ‘‘bronchio-
litis obliterans organising pneumonia’’ or ‘‘BOOP’’ by pathol-
ogists. Today we use the term ‘‘OP pattern’’ as a more generic
descriptor of the lesion and to avoid potential confusion with
‘‘idiopathic BOOP’’ (now cryptogenic organising pneumonia
(COP)). An OP pattern is especially evident in organising acute
lung injury from any aetiology. OP can be accompanied by
alveolar fibrin and/or hyaline membranes if acute injury is
ongoing. This morphology typically will be associated with
acute illness, whereas the patient with a pure OP pattern will
often have a more subacute presentation.
OP is seen in a number of settings (see below), most notably
in COP, a form of idiopathic ILD.
31 The most consistent finding
in COP is patchy involvement of the airspaces by small tufts of
immature fibroblasts distributed within terminal bronchioles,
alveolar ducts and alveoli (fig 20). Other findings that may
accompany an OP pattern include interstitial infiltrates of
mononuclear cells, fibrinous exudates, foam cells in the
airspaces and prominent type II pneumocytes. Common causes
of an OP pattern are presented in box 5.
4b: alveolar filling with macrophages (DIP-like reaction)
A DIP-like pattern is characterised by increased numbers of
alveolar macrophages, with mild associated inflammatory
Figure 18 Granulomatous pneumonia from infection. This example of
atypical mycobacterial infection (Mycobacterium avium complex) differs
from hypersensitivity pneumonitis in having larger and better formed
granulomas, along with more granulomas in the alveolar spaces and
alveolar ducts. Necrosis in granulomas may be present (not in this
image) and is a harbinger of infection. Sarcoidosis granulomas (fig 25)
are better formed, have less associate inflammation, and consistently
have more hyaline fibrosis around aggregated granulomas. H&E stain,
406original magnification.
Figure 19 Pattern 4: alveolar filling. This example of diffuse alveolar
haemorrhage nicely demonstrates the concept of alveolar filling. In cases
of inflammatory reaction to injury, initial interstitial changes typically
evolve to alveolar filling disease (eg, acute bronchopneumonia,
organising pneumonia). H&E stain, 156original magnification.
Figure 20 Cryptogenic organising pneumonia (COP). The most
consistent finding in COP is patchy involvement of the airspaces by small
tufts of immature fibroblasts distributed within terminal bronchioles,
alveolar ducts and alveoli. H&E stain, 406original magnification.
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pattern (in some cases focally) are presented in box 6.
The idiopathic form of DIP described by Carrington
represents a distinct pathological entity that has clinical,
radiological and prognostic differences from idiopathic UIP.
32
Some cases previously classified as DIP can be reasonably
reclassified as RB-ILD, an ILD of smokers that does not appear
to progress to advanced fibrosis.
33
The cytological features of the macrophages in all of these
conditions vary considerably and are helpful at times in
pointing to a specific diagnosis. In RB-ILD, the macrophages
are airway-centred and contain fine, light-brown, cytoplasmic
pigmentation with delicate black punctation, findings charac-
teristic of smokers’ macrophages. In amiodarone reactions,
obstructive pneumonias, lipoid pneumonia and storage diseases,
foamy or vacuolated histiocytes predominate. In hard metal
disease (cobalt pneumoconiosis), distinctive multinucleated
intra-alveolar histiocytes are the dominant finding.
34 Chronic
alveolar haemorrhage is associated with extensive haemosiderin-
laden macrophages in the airspaces.
14 The distinctive features of
eosinophilic pneumonia are the presence of interstitial and
airspace eosinophils, airspace fibrin, markedly reactive type II
cells and dense alveolar macrophages.
12 Birefringent material can
be identified within the DIP-like reaction in many of the
pneumoconioses. Large and small clear spaces, often engulfed by
giant cells and associated with variable fibrosis, characterise
exogenous lipoid pneumonia (fig 22).
4c: alveolar filling with eosinophilic material
The prototype of this pattern is pulmonary alveolar proteinosis
(PAP). This distinctive disease results in dense granular
Box 5: common causes of the organising pneumonia
pattern (modified from Leslie et al)
1
c Organising infections (any cause)
c Organising diffuse alveolar damage
c Hypersensitivity pneumonitis
c Organising infectious pneumonias in:
– chronic bronchitis and emphysema
– bronchiectasis
– cystic fibrosis
– aspiration pneumonia
– chronic bronchiolitis
c Drug and toxin reactions
c Systemic collagen vascular diseases
c Eosinophilic pneumonia
c Airway obstruction
c Cryptogenic organising pneumonia
c Peripheral reaction around:
– abscesses
– infarcts
– Wegener granulomatosis
– others
Figure 21 Desquamative interstitial pneumonia (DIP). Idiopathic DIP is
characterised by dense alveolar macrophages. Many conditions can
result in localised alveolar macrophage accumulation. Inset: alveolar
macrophage detail. H&E stain, 406original magnification (inset, 4006
original magnification).
Box 6: conditions associated with a desquamative
interstitial pneumonia (DIP)-like reaction (modified from
Leslie et al
1)
c Obstructive pneumonias (with foamy alveolar macrophages)
c Exogenous lipoid pneumonia and lipid storage diseases
c Infection in the immunosuppressed patient (‘‘histiocytic
pneumonia’’)
c Respiratory bronchiolitis-associated interstitial lung disease
c Pulmonary Langerhans cell histiocytosis
c Drug reactions
c Chronic alveolar haemorrhage
c Eosinophilic pneumonia
c Certain pneumoconioses (especially talcosis, hard metal
disease and asbestosis)
c Idiopathic DIP
Figure 22 Exogenous lipoid pneumonia.
The microscopic appearance of
exogenous lipoid pneumonia is dependent
on the composition of the aspirated
material. (A) Exogenous lipoid pneumonia
with histiocytes containing predominantly
fine microvesicles. (B) Exogenous lipoid
pneumonia with larger vacuoles and
associated fibrosis. (A,B) H&E stain, 406
original magnification.
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segmental in distribution. Cholesterol clefts and hyaline globules
are typically present in the granular infiltrates, and a rim of
retraction often separates the infiltrates from adjacent alveolar
walls (fig 23). The disease occurs commonly as a primary
idiopathicform,but may alsobeseenasasecondaryphenomenon
in the settings of occupational disease (especially dust-related),
drug-inducedinjury,haematologicaldiseasesandinmanysettings
of immunodeficiency.
35 36 The granularity of the alveolar material
helps differentiate PAP from other alveolar filling processes (such
as pulmonary oedema and Pneumocystis infection).
4d: alveolar filling with blood and siderophages
Alveolar haemorrhage syndromes (discussed under pattern 1d)
are the diagnosis of exclusion for this alveolar filling pattern.
Sometimes striking alveolar haemorrhage can be seen in urgent
lobectomy specimens from patients with persistent haemopty-
sis related to bronchiectasis or other airway/vascular abnorm-
ality. As always, the clinical context is essential, as this is most
often a localised (ie, lobar) phenomenon.
4e: alveolar filling with neutrophils
Acute infectious bronchopneumonia is the prototype for alveolar
filling withneutrophils.Thispattern ismostcommonlyidentified
in autopsy material and rare in surgical biopsy specimens. When
this pattern is seen very focally in the specimen, consider other
causes of neutrophil exudation, particularly capillaritis in diffuse
alveolar haemorrhage.
PATTERN 5: NODULES
Basic elements of the pattern: nodules in the biopsy
specimen, well or poorly formed, large or small, single or
numerous (fig 24)
Key modifiers: with lymphoid cells, with atypical cells, with
well-formed granulomas, with macrophages and dust, with
Langerhans cells and stellate scars, with OP.
Pattern 5 is dominated by neoplastic diseases, especially when
a single or limited number of unilateral nodules are present on
HRCT. The spectrum of isolated neoplastic disease is beyond
the scope of this work and is not discussed. When nodules are
small, bilateral and numerous, nodular forms of ILD enter the
differential diagnosis. Randomly distributed nodular lesions
often dominate the pathology of miliary infections such as
miliary tuberculosis or other disseminated infections. We will
explore three types of diffuse nodular lung disease: granulomas,
nodules in silicate disease and nodular LCH.
5a: nodules with granulomatous inflammation
Relatively few diffuse interstitial pneumonias are dominated by
the presence of granulomas, either necrotising or non-necrotis-
ing in type. These are presented in box 7.
Specific clues to the aetiology of granulomatous interstitial
pneumonias include the anatomical distribution, and the
qualitative features of the granulomas themselves.
38 In sarcoi-
dosis and berylliosis, conglomerates of non-necrotising granu-
lomas are present in a distribution following lymphatic routes.
39
These granulomas tend to be surrounded by dense, brightly
eosinophilic lamellar collagen, and adjacent granulomas have a
tendency to coalesce within this matrix (fig 25). Infectious
granulomas may be solitary or confluent, and may or may not
be associated with necrosis. Necrosis, particularly if micro-
abscess-like, should raise suspicion for infection and lead to
rigorous exclusion with special stains and cultures. Although
necrosis may be seen rarely in the granulomas of sarcoidosis and
berylliosis, as a rule, the necrosis in the latter granulomas has a
more fibrinoid or hyaline appearance and is probably a
degenerative phenomenon.
Regardless of specific aetiology, all granulomas can be
associated with distinctive inclusions, such as the haematox-
yphilic Schaumann body, lucent oxalate crystals and eosino-
philic asteroid bodies in the cytoplasm of multinucleate giant
cells. Oxalate crystals are brightly birefringent in polarised light
and should not be confused with foreign material or a
pneumoconiosis.
Figure 24 Pattern 5: nodules. In pattern 5, nodules may be well or
poorly formed, large or small, single or numerous. This is a patient with
sarcoidosis. H&E stain, 156original magnification.
Box 7: diffuse diseases associated with nodular
granulomatous inflammation
37
c Granulomatous infections
c Sarcoidosis
c Rheumatoid nodules
c Intravenous talcosis
c Pneumoconioses (eg, inhalation talcosis, berylliosis)
c Aspiration pneumonia
Figure 23 Pulmonary alveolar proteinosis (PAP). All of the diagnostic
features of PAP are identifiable in this image: alveolar exudates with an
eosinophilic granular appearance, scattered larger inclusions with more
intense eosin staining, and slight retraction effect at the periphery of the
alveolus. H&E stain, 406original magnification.
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The nodules of silicosis and silicatosis tend to be round and
variably fibrotic. The fibrosis may have a whorled, lamellar or
hyaline character, and almost invariably there will be admixed
polarisable silicates (aluminium and magnesium salts of silica).
40
Like sarcoidosis and lymphangitic neoplasms, many pneumo-
conioses will have a lymphatic pattern (disease occurring along
bronchovascular bundles, interlobular septa and pleura) when
observed at scanning magnification (fig 26). Pathologists rarely
make the diagnosis of pneumoconiosis on lung biopsy speci-
mens, as this must be performed within the clinical and
radiological context.
5c: nodules with Langerhans cells and stellate scars
The nodular lesions of LCH have a mixed composition,
including fibroblasts, collagen, Langerhans cells and pigmented
alveolar macrophages.
24 The nodular phase of LCH can be
sufficiently cellular to suggest neoplasm (fig 27). In my
experience the nodules of LCH often coexist in the biopsy
specimen with variably cellular stellate scars, and these tend to
have fewer Langerhans cells than the nodular form.
PATTERN 6: MINIMAL CHANGES
Basic elements of the pattern: little evident pathology at
scanning magnification (fig 28)
Key modifiers: with constrictive bronchiolitis, with vascular
or lymphatic pathology, with cysts.
6a: minimal changes with constrictive bronchiolitis
The lung biopsy sample from a patient with clinical evidence of
ILD may appear normal.
41 A ‘‘normal’’ biopsy specimen in a
patient with clinical evidence of ILD should lead to a review of
the clinical and HRCT findings. Some of the conditions
associated with pattern 6 may present with more dramatic
findings in the biopsy specimen, but these are the diseases that
can have subtle pathology and cause confusion for the
histopathologist. Chronic passive cardiac congestion and pul-
monary veno-occlusive disease may manifest as ILD. Early
pulmonary oedema or early diffuse alveolar damage may feature
endothelial vacuolisation, lymphatic dilatation and interstitial
widening. Embolic diseases (eg, fat, fibrin) should be considered
in the appropriate clinical setting.
Pathological changes in constrictive bronchiolitis may be quite
subtle under the microscope, despite significant clinical and
radiologicalevidenceofILD(fig29).Changesincludeadecreasein
airwaylumensizeorcompleteobliterationofterminalairwaysto
a variable degree, muscular hypertrophy, submucosal fibrous
thickening, mild chronic inflammation, ectasia with mucostasis,
peribronchiolar scarring and metaplastic bronchiolar epithelium
that extends along surrounding alveolar walls. Although most
cases that show these features are associated with airflow
obstruction and radiographic hyperinflation, a small and ill-
definedgroupofpatientswithsmall-airwaysdiseasealonepresent
with clinical ILD, clinically and radiologically indistinguishable
Figure 25 Sarcoidosis. Sarcoid granulomas surrounded by dense,
brightly eosinophilic lamellar collagen. Note the rosette-like adventitial
distribution in this example. The central structure in this image is a
pulmonary artery. H&E stain, 406original magnification.
Figure 26 Silicatosis. Similar to sarcoidosis in distribution, the nodules
of silicate disease can be distinguished by the common occurrence of
dark pigment dust and the characteristic fibroblastic proliferation that
occurs in response to silicate dust. When these morphological features
are present, refractile silicate particles that rotate plane-polarised light
are always present. This was a patient with mixed dust pneumoconiosis.
H&E stain, 406original magnification.
Figure 27 Langerhans cell histiocytosis
(LCH). LCH has variable morphology. The
cellular form can suggest neoplasm (A).
At higher magnification, the characteristic
admixture of pale amphophilic
Langerhans cells, lightly pigmented
macrophages and eosinophils confirms
the diagnosis (B). (A,B) H&E stain;
(A) 406original magnification; (B) 4006
original magnification.
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42InspiratoryandexpiratoryHRCTscansmaybe
helpful in this setting by showing mosaic attenuation in the
expiratory phase images.
6b: minimal changes with vascular or lymphatic pathology
Diseases affecting the pulmonary arteries, veins and lymphatics
canproducesubtlechangesinthesurgicallungbiopsyspecimen.A
careful and systematic evaluation of these structures is always
justified when pattern 6 is encountered. When chronic disease is
presentinthebronchioles(suchasmayoccurwithperibronchiolar
metaplasia and constrictive bronchiolitis), the adjacent arteries
maybecomeirregularlythickenedandtortuouswithoutapparent
physiological consequences of pulmonary hypertension. Before
consideringa histopathologicaldiagnosisof pulmonaryhyperten-
sion, plexiform lesions (fig 30) or many hypereosinophilic
arterioles with concentric luminal compromise (to the point of
near-obliteration) should be evident.
6c: minimal changes with cysts
Lymphangioleiomyomatosis is the prototype cystic lung disease
which can be quite subtle in surgical lung biopsy samples. In
well-prepared specimens (best achieved by removing the staples
and then shaking the wedge specimen in fixative before
sectioning), the cysts will be apparent at scanning magnifica-
tion. Once identified, a search for thickened cellular areas of the
cyst wall is often fruitful (fig 31). Immunohistochemical stains
(HMB-45, Melan-A, oestrogen and progesterone receptors) are
sometimes helpful in identifying the abnormal smooth muscle
in this disorder.
THE TRANSBRONCHIAL BIOPSY
The pattern-based approach works also for the limited samples
obtained by transbronchial biopsy.
4 The size limitation here
requires a somewhat more focused evaluation. The patterns of
the transbronchial biopsy are presented in box 8.
A WORD ON PATTERNS OCCURRING TOGETHER
Inevitably, some overlap occurs between patterns, and this can
be a useful guide to the correct diagnosis. For example, some
infections are both nodular and have airspace filling (eg,
botryomycosis, aspiration pneumonia), whereas others are
Figure 29 Constrictive bronchiolitis. The injury in constrictive
bronchiolitis is often multifocal, resulting in varicosity of the terminal
airways. Here a small scarred bronchiole is present next to two profiles
of a recently bifurcated pulmonary artery. H&E stain, 406original
magnification.
Figure 30 Plexiform lesion of pulmonary hypertension. This classical
plexiform lesion is composed of a pulmonary artery profile (upper right of
centre) with an adjacent glomeruloid structure (lower left of centre). An
early dilatation lesion is also present here (thin-walled, dilated vessels at
the edges of the complex). H&E stain, 406original magnification.
Figure 31 Lymphangioleiomyomatosis. The cysts of
lymphangioleiomyomatosis can be quite subtle in surgical lung biopsy
samples. Once a cyst is identified, a search for thickened cellular areas
of the wall will reveal the aggregated fascicles of hyperchromatic and
slightly disorganised smooth muscle of lymphangioleiomyomatosis
(inset). H&E stain, 156original magnification; inset: 4006original
magnification.
Figure 28 Pattern 6: minimal changes. Pattern 6 is defined by little
evident pathology at scanning magnification. This patient has
constrictive bronchiolitis and was severely hypoxic. There should be a
bronchiole for nearly every pulmonary artery in this field (and the pair
should be of nearly equal diameter in cross-section). H&E stain, 156
original magnification.
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(eg, pneumoccocal pneumonia, pneumocystis pneumonia). In
fact, for some diffuse inflammatory conditions in the lung, all
six patterns may be present in different areas of the same biopsy
specimen (a nice example of this can be found in patients with
‘‘rheumatoid lung’’).
In practice, recognising the dominant pattern is essential to
navigating the differential diagnosis and addressing the primary
clinical concern. As mentioned above, certain patterns should be
considered dominant over others on the basis of clinical
concerns. Acute lung injury (pattern 1) always trumps other
patterns, given the acuity of the clinical presentation when this
pattern is present and the potentially lethal immediate
consequences. For example, if the biopsy specimen shows
alveolar fibrin with areas of alveolar filling by OP, the successful
student of the six-pattern approach would report the diagnosis
as ‘‘Acute fibrinous lung injury with organisation. Special stains
for organisms are negative. The differential diagnosis includes
infection, toxic reaction to drug or medication, an acute
manifestation of systemic autoimmune disease in the lung,
and an idiopathic form.’’
SUMMARY
An organised approach to the diagnosis of ILD relies on six basic
histopathological reaction patterns. Additional microscopic
features help to narrow the differential diagnosis. A pattern-
based histopathological approach is enhanced and made more
relevant with knowledge of the patient’s clinical and radi-
ological patterns of disease.
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Box 8: transbronchial biopsy patterns in diffuse lung
disease
4
c Acute or subacute injury
c Cellular infiltrates
c Granulomas and lymphangitic tumour
c Vascular diseases (including vasculitis/diffuse alveolar
haemorrhage, pulmonary hypertension and intravenous drug
abuse microangiopathy)
c Alveolar filling processes such as alveolar proteinosis
c Distinctive lesions such as pulmonary Langerhans cell
histiocytosis, lymphangioleiomyomatosis and alveolar
microlithiasis
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